EMBC
NASDAQ · Health Care
Embecta Corp
$3.11
+0.02 (+0.65%)
Financial Highlights (FY 2026)
Revenue
1.10B
Net Income
96.69M
Gross Margin
63.9%
Profit Margin
8.8%
Rev Growth
-1.5%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 63.9% | 63.9% | 33.7% | 33.7% |
| Operating Margin | 22.4% | 20.2% | 21.4% | 22.2% |
| Profit Margin | 8.8% | 8.4% | 16.0% | 18.6% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.10B | 1.11B | 208.68M | 156.81M |
| Gross Profit | 699.27M | 709.71M | 70.24M | 52.78M |
| Operating Income | 245.39M | 224.15M | 44.63M | 34.84M |
| Net Income | 96.69M | 88.32M | 33.44M | 29.22M |
| Gross Margin | 63.9% | 63.9% | 33.7% | 33.7% |
| Operating Margin | 22.4% | 20.2% | 21.4% | 22.2% |
| Profit Margin | 8.8% | 8.4% | 16.0% | 18.6% |
| Rev Growth | -1.5% | -1.5% | -8.7% | -9.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 220.14M | 224.10M |
| Total Equity | — | — | 442.01M | 483.57M |
| D/E Ratio | — | — | 0.50 | 0.46 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 286.62M | 276.35M | 58.64M | 45.10M |
| Free Cash Flow | — | — | 30.27M | 26.47M |